Genetic testing for diseases associated with mental retardation;Genetische diagnostik bei mentaler retardierung

LaboratoriumsMedizin

Volumn 29, Issue 3, 2005, Pages 152-161

  Rost, Imma ^a   Klein, Hanns Georg ^a  

^a Zentrum fur Humangenetik und Laboratoriumsmedizin Dr Klein und Dr Rost   (Germany)

Author keywords

Genetic testing; Mental retardation

Indexed keywords

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FAMILY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HAPPY PUPPET SYNDROME; KARYOTYPING; MENTAL DEFICIENCY; METHYLATION; MICROSATELLITE MARKER; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRADER WILLI SYNDROME; PREGNANCY; QUANTITATIVE ANALYSIS; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; SOUTHERN BLOTTING; STRUCTURAL CHROMOSOME ABERRATION; TELOMERE; UNIPARENTAL DISOMY;

EID: 23944450590     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/JLM.2005.024     Document Type: Article

References (25)

1. Leitlinien der Deutschen Gesellschaft für Neuropädiatrie zur Abklärung der mentalen Retardierung. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, 2001. URL: http://www.awmf-online.de.
2. Inlow JK, Restifo LL. Molecular and comparative genetics of mental retardation. Genetics 2004;166:235-81.
3. McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders, and etiology. Am J Ment Retard 1987;92:243-54.
4. Gripenberg U, Hongell K, Knuutila S, Kahkonen M, Leisti J. A chromosome survey of 1062 mentally retarded patients. Evaluation of a long-term study at the Rinnekoti institution, Finland. Hereditas 1980;92:223-8.
5. Battaglia A, Carey JC. Diagnostic evaluation of developmental delay/mental retardation: An overview. Am J Med Genet C Semin Med Genet 2003;117:3-14.
6. Yorifuji T, Muroi J, Uematsu A, Tanaka K, Kiwaki K, Endo F, et al. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin Genet 1998;54:349-53.
7. Molinari F, Rio M, Meskenaite V, Encha-Razavi F, Auge J, Bacq D, et al. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 2002;298:1779-81.
8. Tariverdian G, Vogel F. Some problems in the genetics of X-linked mental retardation. Cytogenet Cell Genet 2000;91:278-84.
9. Ropers HH, Hamel BCJ. X-linked mental retardation. Nat Rev Genet 2005;6:46-57.
10. Online Mendelian Inheritance in Man, OMIM (TM). Mc-Kusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2000. URL: http://www.ncbi.nlm.nih.gov/omim/
11. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995;9:132-40.
12. Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999;354:1676-81.
13. de Vries BB, White SM, Knight SJ, Regan R, Homfray T, Young ID, et al. Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet 2001;38:145-50.
14. Walter S, Sandig K, Hinkel GK, Mitulla B, Ounap K, Sims G, et al. Subtelomere FISH in 50 children with mental retardation and minor anomalies, identified by a checklist, detects 10 rearrangements including a de novo balanced translocation of chromosomes 17p13.3 and 20q13.33. Am J Med Genet 2004;128:364-73.
15. Horsthemke B, Dittrich B, Buiting K. Imprinting mutations on human chromosome 15. Hum Mutat 1997;10:329-37.
16. Rost I. Chromosomale Mikrodeletionssyndrome. Monatsschr Kinderheilkd 2000;148:55-69.
17. Leitlinien der Deutschen Gesellschaft für Humangenetik und des Berufsverbands Medizinische Genetik e.V., Molekulare und cytogenetische Diagnostik bei Prader-Willi- und Angelman-Syndrom. Zeitschrift Medizinische Genetik 2001;13:71-3.
18. Oostra BA, Chiurazzi P. The fragile X gene and its function. Clin Genet 2001;60:399-408.
19. Hagerman RJ, Hagerman PJ. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 2002;12:278-83.
20. Leitlinien zur molekulargenetischen Diagnostik beim fra(X)-Syndrom des Berufsverbandes Deutscher Humangenetiker. Zeitschrift Medizinische Genetik 2004;16:351-7.
21. Moog U, Smeets EE, van Roozendaal KE, Schoenmakers S, Herbergs J, Schoonbrood-Lenssen AM, et al. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003;7:5-12.
22. Kriaucionis S, Bird A. DNA methylation and Rett Syndrome. Human Molecular Genetics 2003;12:R221-7.
23. Ylisaukko-Oja T, Rehnstrom K, Vanhala R, Kempas E, von Koskull H, Tengstrom C, et al. MECP2 mutation analysis in patients with mental retardation. Am J Med Genet 2005;132:121-4.
24. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997;15:70-3.
25. Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, et al. Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease. Am J Hum Genet 2005;76:572-80.